Tesamorelin 12mg+Ipamorelin 6mg

Compound Overview

Research Use Only. Not for Human Consumption.

Tesamorelin 12mg+Ipamorelin 6mg is a Nexus-only multi-peptide research blend supplied as an 18mg lyophilized powder configuration. The source record identifies two listed components: Tesamorelin at 12mg and Ipamorelin at 6mg. Tesamorelin is listed as the GHRH analog component, and Ipamorelin is listed as the GHSR agonist component.

This product belongs to the Growth Hormone Secretagogues category and is listed under SKU TI18. The supplied chemistry record describes the item as a blend of tesamorelin and ipamorelin rather than as a single discrete molecular entity. For that reason, no single molecular formula, molecular weight, sequence, or CAS number applies to the complete product in the provided data.

The available factual record for this exact blend is intentionally limited. This page does not add unsupported chemistry, component sequences, molecular weights, CAS identifiers, formula data, purity percentages, COA results, batch numbers, literature claims, dosage language, human-use guidance, veterinary-use guidance, or therapeutic claims. Any component-level chemistry should be reviewed through validated individual component records rather than inferred from the blend name.

Research Background & Published Literature

The supplied research overview identifies TI18 as a Nexus-only GHRH/GHSR-pathway research blend. That classification is used here only to describe the pathway categories assigned to the two listed components in the source data. The record does not provide blend-specific experimental abstracts, peer-reviewed citations, assay concentrations, study models, endpoint summaries, or literature references for the exact 12mg+6mg configuration.

The only source listed in the supplied research data is the raw Nexus catalog record. No external literature source, component monograph, analytical worksheet, or lot-specific COA file is attached to this generated description.

Because no citations are supplied for this exact blend, no published literature claims are added to this description. Researchers evaluating the product should treat it as a blend record and separately assess the Tesamorelin and Ipamorelin component references using validated source material available to their laboratory.

The research file specifies that a Certificate of Analysis should verify both component identities and mass allocation. That distinction is important for a multi-peptide material: analytical review should confirm the presence and allocation of each named component rather than treating the product as one molecule with a single formula, single molecular weight, single sequence, or single CAS number.

Researchers reviewing the literature around this compound can use the peer-reviewed resources below for additional context on mechanism of action, signaling pathways, and controlled laboratory research applications:

• Raun et al. (1998) — Eur J Endocrinol
• Matsumoto et al. (2001) — Biochem Biophys Res Commun
• Stanley et al. (2012) — Clin Infect Dis

Storage, Handling & Stability Guidelines

Store lyophilized Tesamorelin 12mg+Ipamorelin 6mg material at -20°C, desiccated, and protected from light. These are the storage conditions provided in the source record for this exact blend.

Use the applicable lot/source record for storage of unopened material. Any diluent selection, preparation, temperature, aliquoting, or post-reconstitution hold conditions must be established by a qualified laboratory under a validated SOP; this page does not establish a stability window.

• Maintain protection from moisture and light during storage and handling.
• Use a validated laboratory SOP and the applicable lot/source record for any preparation or post-reconstitution handling.
• Do not assign a blend-level molecular weight, formula, CAS number, or sequence unless confirmed by validated source documentation.
• Retain internal records that identify the product name, SKU, total blend amount, component allocation, and reconstitution date when applicable.
• Handle the material only under appropriate in-vitro research procedures and institutional chemical-safety requirements.

Quality Assurance & Lab Verification

The Certificate of Analysis for this catalog item is pending. No provisional batch, assay, method, analyst, or release data is published in this product dossier. Check the Lab Verified archive for documentation status.